Levels of Selected Matrix Metalloproteinases, Their Inhibitors in Saliva, and Oral Status in Juvenile Idiopathic Arthritis Patients vs. Healthy Controls

Table 5

Correlations of MMPs and their inhibitors with clinical oral parameters in the course of JIA and in the C group in mixed dentition (MD) and permanent (PD) dentition children.

Dentition type		Salivary parameters
		MMP-2		MMP-8		MMP-9		TIMP-1		TIMP-2
		r	p	r	p	r	p	r	p	r	p
JIA-MD	DMFT	0.49	0.064	0.47	0.075	0.43	0.113	−0.08	0.782	0.25	0.363
	D	0.2	0.48	0.54	0.037	0.42	0.12	0.19	0.49	0.41	0.13
	OHI-S	0.12	0.677	0.03	0.923	0.01	0.975	0.09	0.757	−0.13	0.644
	GI	0.08	0.789	−0.04	0.874	0.15	0.596	0.41	0.130	0.11	0.700
	PBI	0.08	0.770	0.23	0.415	0.43	0.112	0.75	0.001	0.42	0.121
	SF	−0.18	0.532	0.04	0.894	−0.22	0.431	−0.63	0.012	−0.29	0.286
C-MD	DMFT	0.15	0.593	−0.48	0.071	−0.45	0.094	0.21	0.461	−0.26	0.344
	D	0.5	0.06	0.02	0.932	−0.07	0.81	0.21	0.45	0.51	0.054
	OHI-S	−0.06	0.824	−0.03	0.929	−0.11	0.706	−0.06	0.819	−0.12	0.678
	GI	−0.05	0.860	0.07	0.797	−0.02	0.930	0.21	0.452	−0.16	0.570
	PBI	0.13	0.641	0.41	0.134	0.07	0.806	−0.16	0.578	0.10	0.731
	SF	0.15	0.593	0.06	0.829	−0.07	0.801	−0.24	0.388	−0.05	0.854
JIA-PD	DMFT	0.23	0.351	0.17	0.494	0.31	0.193	0.28	0.248	0.22	0.371
	D	0.24	0.31	0.25	0.3	0.04	0.88	−0.24	0.33	−0.11	0.65
	OHI-S	0.39	0.095	0.27	0.266	0.13	0.583	−0.06	0.821	0.11	0.655
	GI	0.59	0.008	0.48	0.036	0.50	0.027	0.38	0.113	0.40	0.087
	PBI	0.60	0.006	0.35	0.138	0.08	0.757	0.06	0.809	0.12	0.620
	SF	−0.44	0.063	−0.46	0.049	−0.02	0.946	−0.03	0.900	−0.35	0.143
C-PD	DMFT	0.08	0.751	0.03	0.914	−0.04	0.866	0.18	0.463	0.01	0.977
	D	0.09	0.71	−0.01	0.98	0.08	0.75	0.36	0.135	0.05	0.83
	OHI-S	−0.31	0.200	−0.06	0.795	−0.35	0.137	−0.18	0.452	−0.45	0.055
	GI	0.29	0.235	0.19	0.425	−0.22	0.357	−0.12	0.626	−0.07	0.767
	PBI	0.11	0.650	−0.09	0.701	−0.24	0.318	0.004	0.985	−0.10	0.676
	SF	−0.39	0.103	0.08	0.758	−0.37	0.118	−0.44	0.061	−0.47	0.04

Note. Spearman’s rank correlation; statistically significant.